Background illustration for clinical trials search

Vaccines Clinical Trials

Find clinical trials for vaccines. Search for vaccines clinical trials in different cities and states across the United States.

Filter
FeaturedActive & Responsive

A Study on the Efficacy of a Vaccine Against Influenza in Adults ≥65 Years of Age

for
Influenza, Human
Location: West Palm Beach FL
Sponsor: GlaxoSmithKline

Sex: All

Age: 65+

Code: NCT07805707

Phase 3, Recruiting
FeaturedActive & Responsive

Flu and RSV Vaccine Studies for Adults 60+

for
Influenza, Human, Respiratory Syncytial Virus Infections
Location: Brookline MA, Jersey City NJ, Philadelphia PA,

Sex: All

Age: 60+

Recruiting
FeaturedActive & Responsive

Flu Vaccine Studies for Adults 65+

for
Influenza, Human
Location: Brookline MA, Jersey City NJ, Anderson SC,

Sex: All

Age: 65+

Recruiting

Participants receive up to $420 for time and travel

FeaturedActive & Responsive

Pneumococcal (Pneumonia) Vaccine Studies for Healthy Adults

for
Pneumococcal Infections
Location: Lincoln NE

Sex: All

Age: 18 - 70+

Recruiting

Participants receive up to $367 for time and travel

FeaturedActive & Responsive

Epstein-Barr Virus Vaccine Study to Prevent Mono in Healthy Young Adults

for
Epstein-Barr Virus Infections
Location: Omaha NE, Lincoln NE

Sex: All

Age: 18 - 30

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
FeaturedActive & Responsive

C. diff Vaccine Studies for Adults 65+ at Higher Risk of Infection

for
Clostridium Infections
Location: Raleigh NC, Cary NC, Salisbury NC, Savannah GA,

Sex: All

Age: 65+

Recruiting

Participants receive up to $1,470 for time and travel

FeaturedActive & Responsive

COVID-19 Study for People 12+ With a Current Infection Who Are at Higher Risk of Severe Illness

for
COVID-19
Location: Waco TX, Huntington Park CA

Sex: All

Age: 12+

Recruiting

Participants receive up to $259 for time and travel

Active & Responsive

Addressing Unfunded Vaccines Through a Co-payment Mechanism in Pharmacies

for
Preventable Disease, Vaccine
Location: Halifax
Sponsor: Canadian Immunization Research Network

Sex: All

Age: 2+

Code: NCT06489964

Recruiting
Active & Responsive

HER2 Vaccine for Locally Advanced Breast Cancer

for
Breast Cancer, HER2-positive Breast Cancer
Location: Indianapolis IN
Sponsor: Pravin T.P Kaumaya

Sex: All

Age: 18+

Code: NCT06949410

Phase 1, Recruiting
Active & Responsive

TMV Vaccine Therapy Alone and With Pembrolizumab for the Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell Cancer

for
Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,
Location: Atlanta GA
Sponsor: Emory University

Sex: All

Age: 18+

Code: NCT06868433

Phase 1, Recruiting
Active & Responsive

HER-2 B Cell Peptide Vaccine

for
Metastatic Breast Cancer, HER2-positive Breast Cancer,
Location: Indianpolis IN
Sponsor: Pravin T.P Kaumaya

Sex: All

Age: 18+

Code: NCT06414733

Phase 1, Recruiting
Active & Responsive

BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

for
Clinical Stage III Cutaneous Melanoma AJCC v8,
Location: Springfield MA, Saint Johnsbury VT, Lebanon NH,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT05136196

Phase 2, Recruiting
Active & Responsive

Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment

for
Metastatic Head and Neck Squamous Cell Carcinoma,
Location: Boston MA, Saint Johnsbury VT, Lebanon NH, Commack NY,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06589804

Phase 3, Recruiting
Active & Responsive

The Natural History of Severe Viral Infections and Characterization of Immune Defects in Patients Without Known Immunocompromise

for
EBV, HSV, VZV, HPV, CMV
Location: Bethesda MD
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Sex: All

Age: 2 - 70+

Code: NCT01011712

Recruiting
Active & Responsive

Prevención en Sus Manos: Feasibility of a Novel Community-Based Strategy to Improve Access to Cervical Cancer Screening

for
HPV
Location: Houston TX, Austin TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT06109870

Recruiting
Active & Responsive

First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer

for
PIK3CA Mutation, Solid Tumor, Adult,
Location: Boston MA, New Haven CT, New York NY, New Brunswick NJ,
Sponsor: Relay Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT05216432

Phase 1, Recruiting
Active & Responsive

Influenza Human Challenge Model

for
Influenza
Location: Atlanta GA
Sponsor: Emory University

Sex: All

Age: 18 - 49

Code: NCT05332899

Phase 1, Recruiting
Active & Responsive

Evaluation of Patients With Liver Disease

for
Hepatitis D, Hepatitis C, Hepatitis B, Liver Disease
Location: Bethesda MD
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Sex: All

Age: 2 - 70+

Code: NCT00001971

Recruiting
Active & Responsive

A/Texas Flu Challenge

for
Influenza
Location: Atlanta GA
Sponsor: Emory University

Sex: All

Age: 18 - 49

Code: NCT06753474

Phase 1, Recruiting
Active & Responsive

Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays

for
Ampulla of Vater Carcinoma, Appendix Carcinoma,
Location: Damariscotta ME, Brunswick ME, Scarborough ME,
Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 18+

Code: NCT07283939

Recruiting

What vaccine clinical trials are studying now

New flu vaccines. Moderna's mFlusiva, approved August 5, 2026 for adults 50 and older, is the first mRNA flu vaccine. In its Phase 3 trial it prevented about 27 percent more flu cases than a standard dose vaccine, with more short term side effects. Flu vaccine studies, including human challenge trials, are listed on our influenza clinical trials page.

Vaccines in pregnancy. Vaccinating a mother so antibodies pass to the baby is one of the most active areas of research. A Phase 3 trial of a group B streptococcus vaccine, a leading cause of serious infection in newborns, is recruiting pregnant participants at 120 US sites.

Pneumococcal and other bacterial vaccines. Next generation vaccines that cover more strains of the bacteria behind pneumonia and meningitis, tested against the vaccines in use today. Two pneumococcal vaccine studies are enrolling healthy adults 18 to 75 who have never had a pneumococcal vaccine.

RSV vaccines. Combination and revaccination studies, covered on our RSV vaccine clinical trials page. Studies of new flu and RSV vaccines for adults 60 and older are enrolling now.

Cancer vaccines. These do not prevent cancer; they teach the immune system to attack a cancer that is already there. Intismeran, made for each patient from up to 34 mutations in their own tumor, met its main goal in a Phase 3 melanoma trial in August 2026 but is not yet approved. Smaller studies test vaccines for HER2 positive breast cancer, liver cancer, and HPV related cancers; see our melanoma and breast cancer pages.

COVID-19. Updated formulas are approved each season; the 2026 to 2027 mRNA formula is approved for adults 65 and older and for people 5 to 64 with a condition that raises their risk. One study is testing a COVID-19 vaccine given during an active infection, for people 12 and older who tested positive within the past 5 days and have a risk factor for severe illness; it measures the immune response and is not a treatment for the current illness. Studies of COVID-19 and long COVID are on our COVID-19 page.

Vaccines for infections that have none yet. There is still no approved vaccine against Epstein-Barr virus, the cause of mono, or against C. difficile, a common hospital infection. A study of an EBV vaccine is enrolling healthy adults 18 to 30, and C. diff vaccine studies are enrolling adults 65 and older who have frequent contact with healthcare but have never had the infection.

Human challenge studies. Healthy adults receive a vaccine or placebo, then a controlled dose of a virus such as influenza, in a monitored setting. They answer in weeks what field trials take seasons to show.

Article preview image

65 or older? Read our guide: Not All Flu Vaccines Work the Same After 65: Which to Choose and When to Get It

Not All Flu Vaccines Work the Same After 65: Which to Choose and When to Get It

How vaccine trials differ from drug trials

Who can participate in vaccine clinical trials?

Do vaccine trial participants get paid?

How to enroll in a vaccine clinical trial